Michael Gable, Author at Fairmont Equities

“Your Stock Request” – 2 April 2020

April 2, 2020 by Michael Gable

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at mail@fairmontequities.com with your stock request. Limit of one per person, no guarantee of a mention. This week’s stock request: (ASX:WPL), (ASX:OZL), (ASX:LYL), (ASX:ALC), (ASX:EHH) Michael Gable is managing director of Fairmont Equities. Latest prices available on the ASX website. You can learn more about technical analysis in this article. An 8-week FREE …

Finding an entry point with Orica

April 1, 2020 by Michael Gable

Investor focus for Orica has shifted dramatically in the last few weeks. The economic implications from the coronavirus (COVID-19) outbreak have challenged previous expectations for: i) Higher ammonium nitrate (AN) volume growth in FY20, ii) Margin recovery to continue, iii) The recent acquisition of Exsa to improve the performance of the Latin America segment and iv) ORI to use its balance sheet to pursue further acquisitions and/or growth initiatives. In this note, we examine the earnings growth and the balance …

“Your Stock Request” – 26 March 2020

March 26, 2020 by Michael Gable

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at mail@fairmontequities.com with your stock request. Limit of one per person, no guarantee of a mention. This week’s stock request: (ASX:EVN), (ASX:QAN), (ASX:WSA), (ASX:Z1P) Michael Gable is managing director of Fairmont Equities. Latest prices available on the ASX website. You can learn more about technical analysis in this article. An 8-week FREE TRIAL …

Asaleo Care not that insulated from coronavirus

March 25, 2020 by Michael Gable

We recently reviewed the fundamentals for Asaleo Care (ASX:AHY) in order to assess the potential for a re-rating in light of the Company now having a more predictable (and defensive) earnings profile. We also looked at the extent to which this factor would insulate earnings during the current coronavirus crisis. About Asaleo Care Asaleo manufactures personal care and hygiene products, which are distributed through retailers, distributors, and directly to corporate accounts. Following the sale of the Consumer Tissue Australia business …